Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 196

1.

Targeting MEK in vemurafenib-resistant hairy cell leukemia.

Caeser R, Collord G, Yao WQ, Chen Z, Vassiliou GS, Beer PA, Du MQ, Scott MA, Follows GA, Hodson DJ.

Leukemia. 2018 Oct 19. doi: 10.1038/s41375-018-0270-2. [Epub ahead of print] No abstract available.

PMID:
30341394
2.

The Prevalence and Associated Factors of Periodontal Disease among 35 to 44-year-old Chinese Adults in the 4th National Oral Health Survey.

Sun HY, Jiang H, Du MQ, Wang X, Feng XP, Hu Y, Lin HC, Wang B, Si Y, Wang CX, Zheng SG, Liu XN, Rong WS, Wan WJ, Tai BJ.

Chin J Dent Res. 2018;21(4):241-247. doi: 10.3290/j.cjdr.a41082.

3.

Dental Caries Status and its Associated Factors among 3- to 5-year-old Children in China: A National Survey.

Du MQ, Li Z, Jiang H, Wang X, Feng XP, Hu Y, Lin HC, Wang B, Si Y, Wang CX, Zheng SG, Liu XN, Rong WS, Wang WJ, Tai BJ.

Chin J Dent Res. 2018;21(3):167-179. doi: 10.3290/j.cjdr.a41076.

4.

Evaluation of Ion Release from Four Dental Sealants.

Chen L, Zeng SJ, Li YH, Du MQ.

Curr Med Sci. 2018 Jun;38(3):524-529. doi: 10.1007/s11596-018-1910-5. Epub 2018 Jun 22.

PMID:
30074222
5.

Genetics of Diffuse Large B-Cell Lymphoma.

Cummin TE, Du MQ, Johnson P.

N Engl J Med. 2018 Aug 2;379(5):493. doi: 10.1056/NEJMc1806191. No abstract available.

PMID:
30070099
6.

Variable Responses of MYC Translocation Positive Lymphoma Cell Lines To Different Combinations of Novel Agents: Impact of BCL2 Family Protein Expression.

Deng W, Clipson A, Liu H, Huang Y, Dobson R, Wang M, Johnson P, Du MQ.

Transl Oncol. 2018 Oct;11(5):1147-1154. doi: 10.1016/j.tranon.2018.07.007. Epub 2018 Jul 25.

7.

Transmission of diffuse large B cell lymphoma by an allogeneic stem-cell transplant.

Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V, Du MQ, Cucco F, Barrans S, Johnson P, Laird SR, Fisher AM, Cullis JO, Graham TA, Okosun J, Fitzgibbon J, Chiecchio L.

Haematologica. 2018 Jul 5. pii: haematol.2018.196907. doi: 10.3324/haematol.2018.196907. [Epub ahead of print] No abstract available.

8.

Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality.

Cucco F, Clipson A, Kennedy H, Sneath Thompson J, Wang M, Barrans S, van Hoppe M, Ochoa Ruiz E, Caddy J, Hamid D, Cummin T, Burton C, Davies AJ, Johnson P, Du MQ.

Lab Invest. 2018 Aug;98(8):1084-1092. doi: 10.1038/s41374-018-0066-z. Epub 2018 May 16.

PMID:
29769698
9.

Novel GPR34 and CCR6 mutation and distinct genetic profiles in MALT lymphomas of different sites.

Moody S, Thompson JS, Chuang SS, Liu H, Raderer M, Vassiliou G, Wlodarska I, Wu F, Cogliatti S, Robson A, Ashton-Key M, Bi Y, Goodlad J, Du MQ.

Haematologica. 2018 Aug;103(8):1329-1336. doi: 10.3324/haematol.2018.191601. Epub 2018 Apr 19.

10.

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.

Horton SJ, Giotopoulos G, Yun H, Vohra S, Sheppard O, Bashford-Rogers R, Rashid M, Clipson A, Chan WI, Sasca D, Yiangou L, Osaki H, Basheer F, Gallipoli P, Burrows N, Erdem A, Sybirna A, Foerster S, Zhao W, Sustic T, Petrunkina Harrison A, Laurenti E, Okosun J, Hodson D, Wright P, Smith KG, Maxwell P, Fitzgibbon J, Du MQ, Adams DJ, Huntly BJP.

Nat Cell Biol. 2017 Sep;19(9):1093-1104. doi: 10.1038/ncb3597. Epub 2017 Aug 21.

11.

Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma.

Moody S, Escudero-Ibarz L, Wang M, Clipson A, Ochoa Ruiz E, Dunn-Walters D, Xue X, Zeng N, Robson A, Chuang SS, Cogliatti S, Liu H, Goodlad J, Ashton-Key M, Raderer M, Bi Y, Du MQ.

J Pathol. 2017 Sep;243(1):3-8. doi: 10.1002/path.4933. Epub 2017 Aug 7.

PMID:
28682481
12.

Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.

Rosenquist R, Beà S, Du MQ, Nadel B, Pan-Hammarström Q.

J Intern Med. 2017 Nov;282(5):371-394. doi: 10.1111/joim.12633. Epub 2017 Jun 20. Review.

PMID:
28631441
13.

MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism.

Du MQ.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):13-23. doi: 10.1016/j.beha.2016.09.002. Epub 2016 Nov 4. Review.

PMID:
28288707
14.

Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.

Wang M, Zhang S, Chuang SS, Ashton-Key M, Ochoa E, Bolli N, Vassiliou G, Gao Z, Du MQ.

Oncotarget. 2017 Mar 14;8(11):17763-17770. doi: 10.18632/oncotarget.14846.

15.

Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.

Rosenquist R, Rosenwald A, Du MQ, Gaidano G, Groenen P, Wotherspoon A, Ghia P, Gaulard P, Campo E, Stamatopoulos K; European Research Initiative on CLL (ERIC) and the European Association for Haematopathology (EAHP).

Haematologica. 2016 Sep;101(9):1002-9. doi: 10.3324/haematol.2015.134510. Review.

16.

Significant functional difference between TNFAIP3 truncation and missense mutants.

Escudero-Ibarz L, Wang M, Du MQ.

Haematologica. 2016 Sep;101(9):e382-4. doi: 10.3324/haematol.2016.148346. Epub 2016 Jun 13. No abstract available.

17.

MALT lymphoma: A paradigm of NF-κB dysregulation.

Du MQ.

Semin Cancer Biol. 2016 Aug;39:49-60. doi: 10.1016/j.semcancer.2016.07.003. Epub 2016 Jul 21. Review.

PMID:
27452667
18.

The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit.

Clipson A, Barrans S, Zeng N, Crouch S, Grigoropoulos NF, Liu H, Kocialkowski S, Wang M, Huang Y, Worrillow L, Goodlad J, Buxton J, Neat M, Fields P, Wilkins B, Grant JW, Wright P, Ei-Daly H, Follows GA, Roman E, Watkins AJ, Johnson PW, Jack A, Du MQ.

J Pathol Clin Res. 2015 Mar 30;1(3):125-133. eCollection 2015 Jul.

19.

Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.

Robles EF, Mena-Varas M, Barrio L, Merino-Cortes SV, Balogh P, Du MQ, Akasaka T, Parker A, Roa S, Panizo C, Martin-Guerrero I, Siebert R, Segura V, Agirre X, Macri-Pellizeri L, Aldaz B, Vilas-Zornoza A, Zhang S, Moody S, Calasanz MJ, Tousseyn T, Broccardo C, Brousset P, Campos-Sanchez E, Cobaleda C, Sanchez-Garcia I, Fernandez-Luna JL, Garcia-Muñoz R, Pena E, Bellosillo B, Salar A, Baptista MJ, Hernandez-Rivas JM, Gonzalez M, Terol MJ, Climent J, Ferrandez A, Sagaert X, Melnick AM, Prosper F, Oscier DG, Carrasco YR, Dyer MJ, Martinez-Climent JA.

Nat Commun. 2016 Jun 14;7:11889. doi: 10.1038/ncomms11889.

20.

Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.

Okosun J, Wolfson RL, Wang J, Araf S, Wilkins L, Castellano BM, Escudero-Ibarz L, Seraihi AF, Richter J, Bernhart SH, Efeyan A, Iqbal S, Matthews J, Clear A, Guerra-Assunção JA, Bödör C, Quentmeier H, Mansbridge C, Johnson P, Davies A, Strefford JC, Packham G, Barrans S, Jack A, Du MQ, Calaminici M, Lister TA, Auer R, Montoto S, Gribben JG, Siebert R, Chelala C, Zoncu R, Sabatini DM, Fitzgibbon J.

Nat Genet. 2016 May 27;48(6):700. doi: 10.1038/ng0616-700b. No abstract available.

PMID:
27230687

Supplemental Content

Support Center